Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,100 | 146 | 52.4% |
| Consulting Fee | $2,290 | 1 | 23.5% |
| Travel and Lodging | $1,697 | 4 | 17.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $481.28 | 3 | 4.9% |
| Education | $114.12 | 2 | 1.2% |
| Entertainment | $26.47 | 1 | 0.3% |
| Gift | $19.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,871 | 42 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $2,343 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $547.91 | 15 | $0 (2024) |
| Notal Vision, Inc. | $497.12 | 4 | $0 (2024) |
| Alimera Sciences, Inc. | $453.49 | 15 | $0 (2023) |
| Allergan, Inc. | $399.45 | 13 | $0 (2021) |
| ABBVIE INC. | $195.87 | 9 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $188.57 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $186.80 | 5 | $0 (2021) |
| Heidelberg Engineering, Inc. | $165.54 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,214 | 31 | Genentech USA, Inc. ($2,547) |
| 2023 | $821.83 | 25 | Genentech USA, Inc. ($200.80) |
| 2022 | $1,038 | 24 | Genentech USA, Inc. ($264.82) |
| 2021 | $850.90 | 22 | Notal Vision, Inc. ($275.25) |
| 2020 | $284.74 | 15 | Mallinckrodt Hospital Products Inc. ($86.81) |
| 2019 | $480.94 | 14 | Regeneron Healthcare Solutions, Inc. ($127.96) |
| 2018 | $465.98 | 14 | Genentech USA, Inc. ($266.03) |
| 2017 | $571.73 | 13 | Genentech USA, Inc. ($313.45) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | Cash or cash equivalent | $113.28 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | Cash or cash equivalent | $7.53 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: EYE CARE | ||||||
| 11/11/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $98.93 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $40.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Ophthalmology | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $767.73 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $319.27 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $215.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Ophthalmology | ||||||
| 09/13/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Ophthalmology | ||||||
| 09/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Ophthalmology | ||||||
| 08/31/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,290.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/30/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: EYE CARE | ||||||
| 06/07/2024 | Genentech USA, Inc. | Vabysmo | Food and Beverage | In-kind items and services | $32.48 | General |
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $44.04 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,807 | 19,651 | $3.5M | $1.6M |
| 2022 | 15 | 2,007 | 7,468 | $3.2M | $1.5M |
| 2021 | 16 | 2,190 | 6,539 | $3.3M | $1.6M |
| 2020 | 19 | 2,255 | 6,527 | $3.3M | $1.6M |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 115 | 1,070 | $1.4M | $738,505 | 52.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 45 | 14,160 | $853,235 | $411,068 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 469 | 878 | $160,293 | $79,476 | 49.6% |
| J3490 | Unclassified drugs | Office | 2023 | 18 | 45 | $129,200 | $79,290 | 61.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 197 | 858 | $295,828 | $71,069 | 24.0% |
| J3590 | Unclassified biologics | Office | 2023 | 17 | 32 | $114,400 | $67,480 | 59.0% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 16 | 450 | $97,903 | $54,162 | 55.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 20 | 301 | $137,887 | $54,054 | 39.2% |
| 92134 | Imaging of retina | Office | 2023 | 548 | 1,473 | $188,207 | $41,926 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 131 | 131 | $36,681 | $15,588 | 42.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 13 | $60,108 | $10,453 | 17.4% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 17 | 19 | $31,958 | $3,196 | 10.0% |
| 92250 | Photography of the retina | Office | 2023 | 105 | 123 | $19,628 | $3,032 | 15.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 64 | 64 | $3,840 | $1,025 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,881 | $952.42 | 50.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 20 | 20 | $1,100 | $212.04 | 19.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 141 | 1,428 | $1.9M | $1.0M | 54.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 33 | 745 | $342,700 | $166,730 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 512 | 885 | $161,070 | $83,400 | 51.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 196 | 859 | $304,114 | $72,612 | 23.9% |
| 92134 | Imaging of retina | Office | 2022 | 608 | 1,524 | $199,644 | $44,836 | 22.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 12 | 1,440 | $86,400 | $42,972 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 152 | 152 | $42,560 | $18,462 | 43.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 18 | 18 | $92,142 | $15,530 | 16.9% |
| 92250 | Photography of the retina | Office | 2022 | 148 | 179 | $28,998 | $4,551 | 15.7% |
About Dr. Charles Richards, MD
Dr. Charles Richards, MD is a Ophthalmology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952315962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Richards, MD has received a total of $9,728 in payments from pharmaceutical and medical device companies, with $5,214 received in 2024. These payments were reported across 158 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,100).
As a Medicare-enrolled provider, Richards has provided services to 8,259 Medicare beneficiaries, totaling 40,185 services with total Medicare billing of $6.2M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Winston Salem, NC
- Active Since 07/27/2006
- Last Updated 08/27/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1952315962
Products in Payments
- Vabysmo (Drug) $2,716
- EYP-1901 (Drug) $2,240
- Lucentis (Biological) $768.41
- OZURDEX (Drug) $498.99
- EYLEA HD (Biological) $384.99
- EYLEA (Biological) $351.49
- ILUVIEN (Drug) $246.70
- ACTHAR (Biological) $221.77
- Iluvien (Drug) $172.15
- Spectralis (Device) $165.54
- VABYSMO (Drug) $146.92
- Syfovre (Drug) $114.04
- YUTIQ (Drug) $105.82
- BEOVU (Drug) $105.27
- Bromsite (Drug) $73.08
- LOTEMAX SM (Drug) $55.62
- XIPERE (Drug) $54.28
- Izervay (Drug) $52.78
- Cimerli (Biological) $32.27
- California (Device) $26.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Winston Salem
Dr. Rajiv Shah, Md, MD
Ophthalmology — Payments: $951,661
Keith Walter, Md, MD
Ophthalmology — Payments: $722,167
Dr. Vishak John, M.d, M.D
Ophthalmology — Payments: $202,813
Margaret Greven, M.d, M.D
Ophthalmology — Payments: $7,794
Dr. Vickas Khemsara, Md, MD
Ophthalmology — Payments: $6,351
Akshay Mentreddy, Do, DO
Ophthalmology — Payments: $4,975